Suven Pharmaceuticals reports 12% revenue growth for Q2 with strong outlook
Suven Pharmaceuticals Ltd. (BSE: 530239, NSE: SUVENPHARM), a technology-focused Contract Development and Manufacturing Organization (CDMO) headquartered in Hyderabad, announced a 12% year-over-year revenue growth for the second quarter of fiscal year 2025. Driven by a strengthened pipeline, increased customer requests, and key expansions, the company reported revenues of INR 258 crore, marking a steady path […]